Wikipedia -WSS

Wikipedia

author：knowledge 2025-08-23 06:46:07 - browse：68359

KalVista Pharmaceuticals said Tuesday that its oral, on-demand treatment for the swelling “attacks” commonly experienced by patients with a genetic condition called hereditary angioedema achieved the goals of a Phase 3 clinical trial.

Based on the study results, the company plans to submit a marketing application to the Food and Drug Administration by the middle of the year. Regulatory filings in Europe and Japan will be completed later in the year.

In the Phase 3 study involving 136 participants, a low and high dose of Kalvista’s drug, called sebetralstat, showed a median time to the beginning of symptom relief of 1.6 hours and 1.8 hours, respectively, compared to 6.7 hours for a placebo. The result was statistically significant and achieved the study’s main efficacy goal.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Tori Bowie and the unacceptable rates of Black maternal death
Next article： Obesity drugs seen as possible treatment for liver disease MASH

WSS

Pharma’s losing bet in New Jersey

Medicare inequities exacerbate Puerto Rico’s health disparities

Congress: Prevent baby formula shortages by passing a new bill

Dario to buy mental health app maker Twill in cash and stock deal

Dario to buy mental health app maker Twill in cash and stock deal

The world needs the new pandemic treaty

knowledge

Wikipedia

focus

Psychedelics group wrestles with new pharma identity

Louisiana bill approved classifying abortion pills as controlled substances

Apple is now the first public company to be valued at $3 trillion

With competition flaring, obesity drug hits goal in liver disease study

Wildfire smoke exposes gaps in outdoor worker protections

Antivenom research: Lessons from HIV applied in search for universal antidote

Dobbs anniversary: the lost opportunity of abortion as health care

Beyond aggravation: Constipation is an American epidemic

Trump demands the U.S. pay no more for drugs than other countries … again

Why palliative psychiatry is worth discussing

hotspot

Cyberattack on UnitedHealth subsidiary cripples pharmacies, hospitals

A solution to the after

Medicare inequities exacerbate Puerto Rico’s health disparities

Neurocrine Biosciences, biotech based in San Diego, joins PhRMA

Community Health Systems hospitals under DOJ investigation

Achieving telehealth equity for people with hearing loss

entertainment

explore

knowledge

hotspot